July 01, 2008 Archives - Renal and Urology News

Print Issue: July 01, 2008

MRI-TRUS Feasible for Targeted Biopsies

WASHINGTON, D.C.—An imaging technique that combines MRI and transrectal ultrasound (MRI-TRUS) is feasible for performing targeted prostate biopsies. This approach may have some advantages over traditional biopsy methods, researchers said here at the Society of Interventional Radiology annual meeting.

Cryoablation for Unresectable Renal Tumors

WASHINGTON, D.C.—Cryoablation is an appropriate option for patients with unresectable renal masses, but long-term follow-up studies are needed before this modality can be expanded to treatment of all potential surgical candidates, researchers say.

Biomarkers May Gauge Anti-VEGF Therapy

SAN DIEGO—Dutch researchers say that they have identified potential biomarkers which might help physicians monitor the effectiveness of bevacizumab in non-small-cell lung cancer (NSCLC) patients and in patients with advanced kidney cancer treated with sunitinib.

Saskia Santegoets, PhD

PCa Immunotherapy Combo Promising

SAN DIEGO—Dutch researchers have reported preliminary success with a combination of the GVAX immunotherapeutic vaccine and ipilimumab (MDX-010, Medarex, Inc) in patients with metastatic hormone-refractory prostate cancer.

Next post in FDA News